Skip to main content
Top
Published in: Japanese Journal of Radiology 12/2015

01-12-2015 | Original Article

Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres

Authors: Akihiko Seki, Shinichi Hori, Chigusa Shimono

Published in: Japanese Journal of Radiology | Issue 12/2015

Login to get access

Abstract

Purpose

Contrast material pooling on angiography within a tumor bed during embolization for hepatocellular carcinoma (HCC) presents as the vascular lake (VL) phenomenon. This retrospective study aimed to evaluate the frequency and management of VLs during chemoembolization with drug-eluting beads (DEBs) and the relationship between the VL and local response.

Materials and methods

A total of 123 HCC patients without vascular invasion or intrahepatic metastases who underwent chemoembolization with DEBs (50–100 µm superabsorbent polymer microspheres loaded with epirubicin) were enrolled. Gelatin sponge particles (GS) were injected for additional embolization in limited patients with steadily increasing size of VLs during DEB injection. Overall, 338 nodules were divided into three groups: lesions without a VL (non-VL; n = 250); lesions with a VL but without additional GS embolization [VL–GS (−), n = 58]; and lesions with both VL and additional GS embolization [VL–GS (+); n = 30]. The local responses were statistically compared by Fisher’s exact test with the Bonferroni correction.

Results

The frequency of VLs was 26.0 % (88/338). The response rate in the non-VL group (54.0 %) was significantly lower than those in the VL–GS (−) (91.4 %; P < 0.0001) and VL–GS (+) (96.7 %; P < 0.0001) groups.

Conclusions

VL is a common angiographic finding and might be associated with the local response.
Literature
1.
go back to reference Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.PubMedCrossRef Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.PubMedCrossRef
2.
go back to reference Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.PubMedCrossRef Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.PubMedCrossRef
3.
go back to reference Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41–52.PubMedPubMedCentralCrossRef Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41–52.PubMedPubMedCentralCrossRef
4.
go back to reference Kritzinger J, Klass D, Ho S, Lim H, Buczkowski A, Yoshida E, et al. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications. Clin Radiol. 2013;68:1–15.PubMedCrossRef Kritzinger J, Klass D, Ho S, Lim H, Buczkowski A, Yoshida E, et al. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications. Clin Radiol. 2013;68:1–15.PubMedCrossRef
5.
go back to reference Seki A, Hori S, Kobayashi K, Narumiya S. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Intervent Radiol. 2011;34:557–65.PubMedCrossRef Seki A, Hori S, Kobayashi K, Narumiya S. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Intervent Radiol. 2011;34:557–65.PubMedCrossRef
6.
go back to reference Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol. 2008;31:1108–16.PubMedCrossRef Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol. 2008;31:1108–16.PubMedCrossRef
7.
go back to reference Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Intervent Radiol. 2013;36:1527–35.PubMedCrossRef Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Intervent Radiol. 2013;36:1527–35.PubMedCrossRef
8.
go back to reference Jiaqi Y, Hori S, Minamitani K, Hashimoto T, Yoshimura H, Nomura N, et al. A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Nihon Igaku Hoshasen Gakkai Zasshi. 1996;56:19–24.PubMed Jiaqi Y, Hori S, Minamitani K, Hashimoto T, Yoshimura H, Nomura N, et al. A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Nihon Igaku Hoshasen Gakkai Zasshi. 1996;56:19–24.PubMed
9.
go back to reference Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, et al. Chemoembolization of hepatocellular carcinoma with HepaSphere 30–60 µm. Safety and efficacy study. Cardiovasc Intervent Radiol. 2014;37:165–75.PubMedPubMedCentralCrossRef Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, et al. Chemoembolization of hepatocellular carcinoma with HepaSphere 30–60 µm. Safety and efficacy study. Cardiovasc Intervent Radiol. 2014;37:165–75.PubMedPubMedCentralCrossRef
10.
go back to reference Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.PubMedCrossRef Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.PubMedCrossRef
11.
go back to reference Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol. 2000;15:1192–8.PubMedCrossRef Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol. 2000;15:1192–8.PubMedCrossRef
Metadata
Title
Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres
Authors
Akihiko Seki
Shinichi Hori
Chigusa Shimono
Publication date
01-12-2015
Publisher
Springer Japan
Published in
Japanese Journal of Radiology / Issue 12/2015
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-015-0486-2

Other articles of this Issue 12/2015

Japanese Journal of Radiology 12/2015 Go to the issue